ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat immunoglobulin A nephropathy, address chronic kidney disease in specific ...
Immuneering Corporation stays a Strong Buy: pancreatic cancer combo shows 64% 12‑mo OS, strong safety, and clear catalysts ...
13hon MSNOpinion
Attention - The next 100% opportunity could be here: Almonty, RENK, TKMS, and Infineon
Shares related to artificial intelligence continue to be a major focus in the market, even though the initial euphoria has ...
Zacks Small Cap Research on MSN
FBLG: Phase 1/2 trial in diabetic foot ulcers to initiate in 1Q26
FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Approval from HREC for Phase 1/2 Diabetic Foot Ulcer Trial In ...
Omai Gold Mines Corp. is pleased to summarize its 2025 achievements and outline upcoming milestones on its 100%-owned Omai Gold Project in Guyana. These milestones are expected to be catalysts to ...
Where are the gaps in AI governance, Anthropic seeks its third big funding round in a year, humanoid robot hype in 2026.
New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung ...
MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...
Our updated two-round NBA Mock Draft projections include an Indiana Pacers heist, a dangerous Oklahoma City Thunder addition, ...
NervGen Pharma Corp. (“NervGen” or the “Company") (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal ...
Patrick Swayze’s younger brother, Sean Swayze, has died. He was 63. Sean’s son, Jesse, confirmed to TMZ on Wednesday, January 7, that his father died late last month in Los Angeles. A death ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 5 undervalued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results